Digest Network Come funziona
Network
/
Società
Ve
Non verificato

Vergent Bioscience

Di cosa scriviamo

BiotecnologiaIndustriaMedicina - VarieOncologiaSalute

4 comunicati stampa

Guarda tutti i comunicati
22/05/2025
Industria
Biotecnologia
Medicina - Varie
Salute
Oncologia
Vergent Bioscience Presents Phase 2B VISUALIZE Results Demonstrating Abenacianine for Injection (VGT-309) with Intraoperative Molecular Imaging Improved Tumor Visualization During Lung Surgery
Fonte
Vergent Bioscience
Emittente
Business Wire
1.00
0
08/05/2025
Eventi
Oncologia
Attrezzature medico-sanitarie
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Vergent Bioscience to Present Data on Abenacianine for Injection (VGT-309) at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
Fonte
Vergent Bioscience
Emittente
Business Wire
1.00
0
13/11/2024
Industria
Biotecnologia
Salute
Sanità
Farmaceutica
Oncologia
Scienza
Attrezzature medico-sanitarie
Medicina - Varie
Vergent Bioscience Completes Enrollment in Phase 2 VISUALIZE Trial Evaluating Potential of Abenacianine for Injection (VGT-309) to Improve Tumor Visualization During Cancer Surgery
Fonte
Vergent Bioscience
Emittente
Business Wire
1.00
0
18/07/2024
Biotecnologia
Salute
Sanità
Farmaceutica
Oncologia
Scienza
Attrezzature medico-sanitarie
Medicina - Varie
Industria
Vergent Bioscience Data Published in The Annals of Thoracic Surgery Demonstrate VGT-309 May Help Surgeons Visualize Tumor Tissue in the Lung During Surgery
Fonte
Vergent Bioscience
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0